Veronica Sanchez Bulis sold $7K of Lyell Immunopharma stock
By AlphaYouPublished Form 4
Bulis Veronica Sanchez
Reporting filer
Veronica Sanchez Bulis reported selling 416 shares of Lyell Immunopharma, Inc. for about $7K ($15.93 a share on average). Form 4 filed Nov 12, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Bulis Veronica Sanchez | 2026-11-10 | S | Sale | 416 | 15.93 | 14,383 | 2 days | Filed terms
|
Common Stock
- Owner
- Bulis Veronica Sanchez
- Date
- 2026-11-10
- Code
- S
- Action
- Sale
- Quantity
- 416
- Price
- 15.93
- Following holdings
- 14,383
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 416
- id: F1
- transaction Price Per Share: 15.93
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 14383
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Bulis Veronica Sanchez: VP, Corporate Controller.
- F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.